ANI Pharmaceuticals, Inc. ( ANIP ) Q1 2026 Earnings Call May 8, 2026 8:00 AM EDT

Company Participants

Irina Koffler

Nikhil Lalwani - President, CEO & Director

Christopher Mutz - Senior Vp & Head of Rare Disease

Stephen Carey - Senior VP of Finance & CFO

Conference Call Participants

David Amsellem - Piper Sandler & Co., Research Division

Vamil Divan - Guggenheim Securities, LLC, Research Division

Yuchen Ding - Jefferies LLC, Research Division

Glen Santangelo - Barclays Bank PLC, Research Division

Ekaterina Knyazkova - JPMorgan Chase & Co, Research Division

Leszek Sulewski - Truist Securities, Inc., Research Division

Brandon Folkes - H.C. Wainwright & Co, LLC, Research Division

Thomas Smith - Leerink Partners LLC, Research Division

Presentation

Operator

Good day, everyone, and welcome to today's ANI Pharmaceuticals, Inc. First Quarter 2026 Earnings Results Call. Please note this call is being recorded.…